Yingying Du Selected Research

SH-1028

10/2022

Efficacy and Safety of SH-1028 in Patients With EGFR T790M-Positive NSCLC: A Multicenter, Single-Arm, Open-Label, Phase 2 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingying Du Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 03/2009
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 11/2016
5	Adenocarcinoma of Lung 01/2024 - 01/2020
5	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2012
4	Neoplasm Metastasis (Metastasis) 10/2023 - 03/2012
3	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2021
3	Disease Progression 10/2022 - 01/2020
2	Carcinoma (Carcinomatosis) 12/2023 - 12/2022
2	Wounds and Injuries (Trauma) 01/2023 - 03/2020
2	Inflammation (Inflammations) 01/2023 - 12/2022
2	Diarrhea 10/2022 - 01/2021
2	Infections 05/2022 - 01/2018
2	Influenza in Birds (Avian Flu) 11/2018 - 01/2018
2	Placenta Accreta 04/2018 - 08/2016
2	Hemorrhage 04/2018 - 03/2009
1	Leukemoid Reaction 01/2024
1	Liver Neoplasms (Liver Cancer) 12/2023
1	Sepsis (Septicemia) 04/2023
1	Respiratory Hypersensitivity 01/2023
1	Weight Gain 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Clear Cell Sarcoma 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Stress Fractures (Stress Fracture) 12/2022
1	Carcinogenesis 10/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022
1	COVID-19 05/2022
1	Human Influenza (Influenza) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Bacterial Infections (Bacterial Infection) 02/2021
1	Pneumonia (Pneumonitis) 02/2021

Drug/Important Bio-Agent (IBA)

4	ErbB Receptors (EGF Receptor)IBA 01/2024 - 09/2022
4	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2016
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
4	sintilimabIBA 01/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 12/2023 - 11/2022
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2022
2	anlotinibIBA 12/2023 - 12/2022
2	apatinibIBA 12/2023 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2023 - 01/2021
2	CytokinesIBA 01/2023 - 12/2022
2	Phosphotransferases (Kinase)IBA 11/2022 - 07/2015
2	VaccinesIBA 05/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 01/2021 - 11/2016
2	MicroRNAs (MicroRNA)IBA 01/2017 - 03/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2024
1	penpulimabIBA 01/2024
1	Carboplatin (JM8)FDA LinkGeneric 01/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	lorlatinibIBA 01/2024
1	CrizotinibIBA 01/2024
1	alectinibIBA 01/2024
1	Angiogenesis InhibitorsIBA 12/2023
1	camrelizumabIBA 12/2023
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	AZD3759IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023
1	Photosensitizing Agents (Photosensitizers)IBA 05/2023
1	monomethoxypolyethylene glycol (MPEG)IBA 05/2023
1	isothiocyanic acidIBA 05/2023
1	pyrotinibIBA 01/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	SteroidsIBA 01/2023
1	2- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA 01/2023
1	TransferasesIBA 01/2023
1	CollagenIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022
1	larotrectinibIBA 11/2022
1	entrectinibIBA 11/2022
1	tyrosine receptor (receptor, tyrosine)IBA 11/2022
1	SeleniumIBA 10/2022
1	Selenium-Binding ProteinsIBA 10/2022
1	SH-1028IBA 10/2022
1	CreatinineIBA 10/2022
1	TabletsIBA 10/2022
1	Mutant Proteins (Protein, Mutant)IBA 09/2022
1	COVID-19 VaccinesIBA 05/2022
1	human ERBB2 proteinIBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	margetuximabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	EpitopesIBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2021
1	Prednisolone (Predate)FDA LinkGeneric 02/2021

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2024 - 01/2020
10	Therapeutics 01/2024 - 01/2020
5	Immunotherapy 12/2023 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 05/2023 - 01/2021
2	Radiotherapy 01/2022 - 01/2020
2	Cesarean Section (Caesarean Section) 04/2018 - 08/2016
2	Hysterectomy 04/2018 - 08/2016
1	Chemoradiotherapy 01/2024
1	Photothermal Therapy 05/2023
1	Phototherapy (Light Therapy) 05/2023
1	Nephrectomy 12/2022
1	Aftercare (After-Treatment) 12/2022
1	Nanospheres 01/2022